Hilltop Biosciences Inc.

Norwood, MA · Founded 2018 · Biotech · Private

Engineered regenerative therapies for veterinary applications in joint health, soft tissue repair, and ophthalmology

Claim this profile

Follows are private to you and power your alerts

Updated · hilltopbio.com

Sector
Biotech
Headquarters
Norwood, MA
Founded
2018
Latest Form D
$4.3M, Dec 2024
Total capital
$6.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$6.3M
5 Form D · last Dec 2024
22 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
4 pending · first 2024
Rank in peer group#397 of 1449

Capital timeline

201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $6.3M1st Form D$751K2nd Form D$150K3rd Form D$784K4th Form D$295K5th Form D$4.3M
201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $6.3M5th Form D$4.3M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$4.3M
  • Private capital raisedForm D · SEC · 4th filing$295K
  • Private capital raisedForm D · SEC · 3rd filing$784K
  • Private capital raisedForm D · SEC · 2nd filing$150K
  • Private capital raisedForm D · SEC · 1st filing$751K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#397 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Amanda DrobnisResearcherExecutive Officer, DirectorLinked by 1 patent
  • Alan WatsonDirectorNamed in SEC Form D filings
  • Denise BeaversDirectorNamed in SEC Form D filings
  • Denise BeversDirectorNamed in SEC Form D filings
  • Jessica McLearDirectorNamed in SEC Form D filings
  • Jill WittelsDirectorNamed in SEC Form D filings
Show all 7 people
  • Mark WilliamsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 6
Show all 6 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .